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4-Hydroxyaminoquinoline I-oxide (4HAQO) and (±)­
trans-7,8-dihydroxy-9, IO-epoxy-7,8, 9, IO-tetrahydroben­
zo[a]pyrene (BP-DE)-DNA adducts were immunohisto­
chemically demonstrated in the nuclei of mouse skin using 
antibodies directed against carcinogen (4HAQO or BP) 
modified DNA. The specificity of the immunostaining was 
confirmed by several tests, including preincubation of the 
antibody with carcinogen modified DNA or related mole­
cules, and digestion of the sections with DNase. 
Subcutaneous injection of 4HAQO dissolved in isotonic 
solution into an isolated portion of the mouse skin clamped 
off with ring-shaped forceps resulted in dose-dependent gen­
eration of DNA adducts in the nuclei of epithelial cells, fibro-
T he initial step in chemical carcinogenesis is probably the covalent binding of carcinogen to DNA of the target cell. Several carcinogen-DNA adducts have been isolated and their structures identified [1-4]. Al­though studies on the fate of carcinogen adducts in 
the nucleic acids of exposed cells have usually focused on biochemi­
cal and radioimmune assays, more recently specific antibodies have 
been raised against DNA adducts with several kinds of carcinogens. 
Immunologic determination of such adducts has been performed by 
a number of laboratories [5 -15). Thus development of immunohis­
tochemical techniques has allowed visualization of carcinogen­
DNA adduct formation in individual cells or in strata of whole 
tissues [16 - 22). With this method it should be possible to gain a 
better understanding of the relevance of DNA binding and DNA 
repair to the mechanisms underlying chemical carcinogenesis; for 
example, in the skin. 
Antibodies to DNA adducts of two skin carcinogens are the sub­
ject of the present report. 4HAQO, a proximate form of 4-nitro­
quinoline l-oxide [23], which was first demonstrated to induce 
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Abbreviations: 
ABC: avidin-biotin peroxidase complex 
BP: benzo[a]pyrene 
BP-DE: (±)-trans-7,8-dihydroxy-9,IO-epoxy-7,8,9,1O tetrahydro-
benzo[a]pyrene 
DAB: 3,3' -diaminobenzidine, tetrahydrochloride 
4HAQO: 4-hydroxyaminoquinoline I-oxide 
4NQO: 4-nitroquinoline I-oxide 
PBS: phosphate buffered saline 
UDS: unscheduled DNA synthesis 
blasts, and panniculus carnosus cells. BP-DNA adducts could 
also be similarly detected dose-dependently in the nuclei of 
skin cells after local application of BP-DE. Nuclear staining 
was absent in animals injected with isotonic solution alone, 
and the intensity of staining correlated well with the level of 
unscheduled DNA synthesis (UDS) demonstrated auto radio­
graphically after treatment with 4HAQO. Killing of mice at 
different time points after a single injection of 4HAQO re­
vealed a gradual decrease in the intensity of the staining. 
Thus the postulated generation and repair of DNA adducts 
can be followed at the cellular level using the presently de­
scribed method.] Invest DermatoI92:275S-279S, 1989 
tumor development in the skin by Nakahara et al [24], reacts with 
DNA to yield four kinds of adducts: one 4HAQO-adenine and 3 
4HAQO-guanine structures [25]. The second carcinogen, 
benzo[a)pyrene (BP), which is a worldwide environmental contam­
inant and may be directly involved in human carcinogenesis, has the 
anti-form of BP-DE, the ultimate binding species [26,27). 
Specific antibodies raised against 4HAQO-DNA adducts [28,29) 
or BP-DNA ad ducts [30) were used for immunohistochemical de­
tection of nuclear carcinogen-DNA ad ducts in paraffin embedded 
mouse skin sections after application of carcinogens in vivo. Appli­
cation of the method was extended to include studies on adduct 
removal from skin after local or systemic exposure to 4HAQO. 
MATERIALS AND METHODS 
Anti-Carcinogen-DNA Adduct Antibody Antibody specific 
for 4HAQO or BP modified DNA was raised and characterized in 
the same way as previously described [28,30). Briefly, 4HAQO­
DNA or BP-DNA was electrostatically bound to methylated bo­
vine serum albumin (rnBSA), and rabbits were immunized with an 
emulsion of carcinogen-DNA-rnBSA complex with complete or 
incomplete Freund's adjuvant. Blood samples were taken after the 
final injection of the antigen mixture without adjuvant. Serum was 
refined and collected as the IgG fraction. Antibody specificity was 
verified by an enzyme-linked immunosorbent assay. The antibodies 
recognized carcinogen (4HAQO or BP) modified DNA but not 
unmodified DNA, other carcinogen modified DNA or free carcin­
ogen derivatives. 
Immunohistochemical Detection of Carcinogen-DNA Ad­
ducts in the Skin Female ICR mice (8 weeks old), weighing 26 to 
30 g, were obtained from Charles River Japan (Atsugi-shi, Japan). 
For local treatment of mouse skin with carcinogen, the technique 
used was essentially the same as that reported earlier [31,32] and 
thus is only briefly described here. Animals were anesthetized with 
sodium pentobarbital, and the skin of their backs was shaved with 
electric clippers. Tongue forceps (ring shaped, 20 mm in internal 
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diameter), of the type normally used clinically, were used to clamp 
off a double fold of skin, with as little stretching as possible. This 
clamped-off area of skin was then marked with a pen. Immediately 
after the skin was clamped off, 0.5 ml of solution containing differ­
ent concentrations of carcinogen was injected s.c. into the clamped­
off region with a fine needle. To confirm the specificity of the 
immunohistochemical staining, I-methyl- l-nitrosourea (5 X 
10-3 M), methyl methane sulfonate (15 X 10-2 M), or Ringer solu­
tion alone was injected. The mice with shaved skin were also ex­
posed to UV irradiation at a dose of 2600 J/m2 from a sunlamp with 
three 20-watt fluorescent tubes (Toshiba FL 20 S.E. sunlamp) with 
emission at 270 to 440 nm and a peak at 312 nm. 
Three mice each received a single i.v. injection of 4HAQO (Iwai 
Kagaku Co., Tokyo, Japan) solution (dissolved in a small amount of 
0.025 N HCI solution) at doses of 0.5, 5, or 20 mg/kg body weight 
to determine the distribution of adduct throughout the body. The 
mice were killed 3 h later by decapitation, and the skin and the other 
various organs were quickly removed. 
To ascertain any correlation between dose dependencies of stain­
ing and UDS, four animals each were then treated with different 
concentrations of 4HAQO (0.75, 2.5, 7.5, 25, 75, or 
250 X 10-6 M), and [methyPH] thymidine [50.uCi/0.5 mil 
mouse; specific activity 75 Ci/mmol, 100.uCi/ml (New England 
Nuclear, Boston, MA)]. For studies on the time course of DNA 
repair, groups of four mice each received an injection of 4HAQO 
(75 X 10-6 M) and were killed 2, 24, 48, or 72 h after treatment. 
Each experiment included at least four animals treated with Ringer 
solution alone. 
Using the same method as for 4HAQO, three doses of BP-DE 
(5 X 10-4, 1 X 10-4, 2 X 10-5 M: ITT Research Institute, Chicago, 
IL, under the auspices of Dr. Longfellow, National Cancer Insti­
tute, Bethesda, MD) and Ringer solution alone were injected s.c. 
into the clamped-off region. 
Immediately after injection, the mice were kept at 35°C for 60 
min and the forceps were removed. The animals were killed 2 h 
later except those in the repair-time course study. 
Tissue specimens were fixed in 10% neutral formaldehyde solu­
tion for 18 h at room temperature. To obtain identical staining 
conditions, control and carcinogen-exposed tissues were embedded 
in the same paraffin block in all experiments. Paraffin-embedded 
material was sectioned at 3 to 4 .urn, and the sections were mounted 
on glass slides coated with poly(L-lysine). After incubation in meth­
anol with 0.3% H202 for 30 min, dehydration through a graded 
ethanol series was performed. 
To avoid any cross-reaction with RNA, the sections were first 
treated with RNase A (200.ug/ml from bovine pancreas; Sigma 
Chemical Co., St. Louis, MO: pretreated at 70°C for 10 min to 
inactivate DNase). The sections were then treated with 2 N HCI at 
room temperature for 5 h and incubated in 3% normal goat serum 
containing PBS. Binding of anti-carcinogen-DNA adduct antibody 
was carried out at 4 ° C for 16 h and visualized by the avidin-biotin 
peroxidase complex method (Vectastain kit from Vector Laborato­
ries, Inc., Burlingame, CAl with the use of 0.01 % H202 and 0.05% 
DAB (incubation in 0.05 M Tris buffer pH 7.2, for 10 min). After 
washing in deionized water, the sections were dehydrated through 
graded ethanol and xylene, and mounted. 
To confirm the specificity of immunohistochemical staining, an­
tibody was substituted either with normal rabbit sera or specific 
antibody absorbed with an excess of carcinogen modified DNA or 
unmodified DNA. Other sections were incubated with DNaseI 
(from bovine pancreas; Sigma Chemical Co.) diluted to 500 .ug/ml 
with PBS added to 3 mM MgCl2 at 37"C for 4 h before staining 
with the antibody. 
Autoradiographic procedures were performed as previously de­
scribed [31,32]. Skin sections stained for 4HQAO-DNA adduct by 
specific antibody were dip-covered with NR-M2 autoradiographic 
emulsion (Konishiroku Photo Co., Tokyo, Japan) and exposed at 
4 ° C for 4 weeks. Because the range of variability in the grain num­
bers was small throughout any particular sample, grains were 
counted consecutively (in one direction) on more than 200 basal 
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cells starting from a randomly selected point. The background 
grains on control sections were counted in the same way. 
RESULTS 
Immunohistochemical Procedure and Specificity Tests In 
order to determine the most suitable condition for detection of 
carcinogen-DNA adducts, skin samples from mice that received a 
single s.c. injection of 0.5 ml 4HAQO solution (2.5 X 10-4 M) into 
the clamped-off region were used. Cryostat sections and paraffin 
sections from materials fixed in acetone, methanol, Carnoy's solu­
tion, paraformaldehyde, or 10% neutral formaldehyde were tested 
for binding of anti-4HAQO-DNA adduct antibody. Most fixatives 
proved unsuitable, because nuclei of control sections demonstrated 
nonspecific staining. Moreover, some sections deteriorated during 
incubation in 2 N HC!. Paraffin sections fixed in 10% neutral for­
maldehyde, however, had none of these disadvantages and provided 
the best morphologic preservation (Figs 1 and 2). 
A few features of the staining process have to be stressed. For 
example, treatment of tissue sections with HCI was necessary for 
detection of adducts. Optimal HCI concentration, temperature, and 
incubation time were investigated, and it was found that a treatment 
period of 5 hours with 2N HCI at 25°C was associated with a 
maximum amount of DAB precipitate. Treatments for longer than 
5 hours with 2N HCI decreased staining intensity. Treatments of 
sections with RNase before exposure to the specific antibody elimi­
nated cytoplasmic staining but did not affect specific nuclear 
staining. 
Under the chosen experimental conditions, anti-4HAQO-DNA 
adducts antibody did not bind in detectable amounts to tissues of 
unexposed mice (Figs IB and 2B). Control rabbit sera also did not 
react with tissues of 4HAQO-exposed mice (data not shown). In 
sections from mouse skin exposed to sunlamp UV (2600 J/m2), 
Figure 1. Nuclear immunohistochemical staining of 4HAQO-DNA ad­
ducts in skin sections from mice exposed to 4HAQO (A) but not Ringer 
solution (B). 4HAQO solution [75 X 10-6 M] (A) or Ringer solution (B) 
was injected s.c. into regions of skin region clamped with tongue forceps. 
The sections were stained with anti-4HAQO-DNA adduct antibody using 
the ABC method. (Bar: 50 ,um). 
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Figure 2. Nuclear immunohistochemical staining of BP-DNA adducts in 
skin sections from mice exposed to BP-DE (A) but not Ringer solution (B). 
BP-DE solution [2 X 10-5 M] (A) or Ringer solution (B) was injected S.c. 
into regions of skin region clamped with tongue forceps. The sections were 
stained with anti-BP-DNA adduct antibody using the ABC method. (Bar: 
25 11m). 
1-methyl-1-nitrosourea (5 X 10-3 M), or methyl methane sulfo­
nate (1.5 X 10-2 M), nuclear staining was negative with the 
anti-4HAQO-DNA adducts antibody (data not shown). Nuclear 
staining was eliminated when the antibody was mixed with an 
excess of 4HAQO modified DNA prior to incubating sections with 
the antibody, but was hardly changed when the antibody was mixed 
with an excess of unmodified-DNA (data not shown). When sec­
tions were preincubated with DNase before addition of 
anti-4HAQO-DNA adduct antibody, nuclear staining was elimi­
nated (data not shown). These data indicate that recognition by the 
antibody is highly specific for the type of DNA damage caused by 
4HAQO in vivo. 
Essentially the same results were gained with anti-BP-DNA ad­
duct antibody. 
4HAQO-DNA Adducts in Mouse Skin When 4HAQO solu­
tion was injected s.c. into an isolated portion of the mouse skin 
clamped off with ring-shaped forceps, immunohistochemical stain­
ing of DNA adducts was observed in nuclei of epithelial cells, fibro­
blasts, and panniculus carnosus cells (Fig 1A). The level of staining 
observed 3 h after injection of 0.75, 2.5, 7.5, or 250 X 10-6 M 
4HAQO was dose dependent with no significant nuclear binding 
found for the lowest dose (data not shown). UDS was clearly seen as 
silver grains over the nuclei of epithelial cells. A clear correlation 
between 4HAQO dose and levels of UDS and nuclear staining 
(amount of 4HAQO-DNA adducts) was demonstrated. 
Mice killed at 2, 24, 48, or 72 h after injection of 4HAQO re­
vealed a gradual decrease in the intensity of staining of epithelial 
cells between 2 and 72 h (Fig 3), suggesting that repair of the ad­
ducts had taken place. 
Mice that received a single i.v. injection of 4HAQO solution at 5 
or 20 mg/kg and were killed 3 h thereafter demonstrated a pre­
dominance of nuclear staining in organs that were considered tar-
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Figure 3. DNA repair rate of 4HAQO-DNA adducts In mouse skin. 
4HAQO solution [75 X 10-6 M] was injected S.c. into regions of skin region 
clamped with tongue forceps and the skin was removed 2 h (A), 24 h (B), 
48 h (C), or 72 h (D) thereafter. Note the decreasing intensity of staining 
with time (Bar: 24 11m) 37. 
gets for 4HAQO-carcinogenesis: skin, pancreas, uterus, vagIna, 
colon, lung, and trachea (data not shown). 
BP-DNA Adducts in Mouse Skin Mice that received a s.c. injec­
tion of BP-DE solution into an isolated portion of the skin clamped 
off with ring-shaped forceps and who were killed 3 h thereafter 
demonstrated a predominance of nuclear staining in skin cells (Fig 
2). Dose-dependent staining of nuclei of the skin was also observed 
at 3 h after injection of 50, 10, and 2 X 10-5 MOP-DE (data not 
shown). 
DISCUSSION 
DNA repair systems are regarded as among the most important in 
organisms. However, relatively little is known about DNA repair in 
vivo in the skin, because few appropriate methods for studying it are 
available. UV -induced DNA repair has been studied by direct mea­
surement of pyrimidine dimers in the skin [33,34], but while this 
method is specific, it cannot give information on the location of 
DNA repair within individual skin cells. 
Another approach has been our autoradiographic measurement of 
DNA repair at the single cell level in skin in vivo after treatment 
with UV [32] or chemical carcinogen [31]. We used this technique 
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and clarified the following points. a) Epithelial cells are more profi­
cient (3 to 4 times) than fibroblast in DNA excision repair [31,32]; 
b) Sunlamp UV reaches deeper sites in the skin than a germicidal 
lamp [32]; c) DNA repair synthesis is induced rapidly after UV 
irradiation and continues for 48 h [32]; d) cutaneous hair can screen 
about 90% of the UV energy [32] and melanin is less important than 
hair for photoprotection against UV irradiation in guinea pig skin 
[35]; and e) aged animals cannot repair extensive UV -induced DNA 
damage efficiently, but no age-associated changes are observed after 
treatment with 4HAQO [36]. 
The present finding that the intensity of adduct staining in mouse 
skin gradually decreased with passage of time provides further evi­
dence of repair of carcinogen-DNA adducts. Combined immuno­
histochemical staining and auto radiographic methods showed that 
the UDS levels and DNA adducts formation correlated well with 
comparable sensitivities. Although the initial levels of anti-carcino­
gen-DNA adduct binding were similar in both fibroblast and epi­
thelial cells, adducts were removed far more quickly in epithelial 
cells than in fibroblasts where .staining was still apparent 72 h after 
4HAQO injection. This strongly suggests rapid repair in epithelial 
cells, which agrees with the finding that UDS levels in the epithe­
lium are 3 -5 times greater than that found in fibroblasts. 
Previous studies have indicated the utility of carcinogen-DNA 
adduct specific antibodies as tools to probe the relevance of DNA 
ad ducts to carcinogenesis in vivo and in vitro [5- 28]. The precise 
localization of carcinogen-DNA adducts in the series of experi­
ments confirmed the specificity of the anti-carcinogen-DNA ad­
duct antibodies raised. Enzyme-linked immunosorbent assay 
[28,30] and immunohistochemical tests [29] revealed a very high 
affinity of the antibodies for carcinogen-DNA ad ducts and no cross­
reaction with unmodified DNA or other carcinogen modified 
DNA adducts. 
Immunohistochemical staining is suitable for comparative mor­
phologic detection of carcinogen-DNA adducts, while enzyme­
linked immunosorbent assays and radioimmunoassays [5 -15] are 
more sensitive and appropriate for absolute quantitation of carcino­
gen-DNA adducts. Nevertheless, a clear positive correlation be­
tween nuclear staining intensity and dose of carcinogen used was 
observed in the skin. 
The sensitivity of the immunohistochemical method was assessed 
by comparing the results gained with those obtained from radioac­
tive analysis using [3H]-4HAQO. The lowest limit of detection for 
the staining was 3 -5 adducts per 106 nucleotides, that is to say, 
about 104 adducts per cell. This is in the same general range as the 
detection limit of 5 X 104 molecules per cell reported for DNA-06-
ethyldeoxy guanosine in liver sections of rats treated with diethyl­
nitrosamine [22]. 
Thus the presently described simple and highly sensitive method 
for detecting carcinogen-DNA adducts in conventional histologic 
sections should prove useful for future investigation of metabolic 
activation and repair potential at the individual cell level. It would 
appear that generation of equivalent antibodies against other carcin­
ogen-DNA adducts is a high priority for an understanding of the 
role played by such lesions in tumor induction. 
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